stella
beta
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia — Stella
Recruiting
Back to B Acute Lymphoblastic Leukemia trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan
View full record on ClinicalTrials.gov